IL-6 Prevents Hypovolemic Circulatory Collapse in Rats
Author Information
Author(s): Jeffrey A. Alten, Ana Moran, Anna I. Tsimelzon, Mary-Ann A. Mastrangelo, Susan G. Hilsenbeck, Valeria Poli, David J. Tweardy
Primary Institution: Baylor College of Medicine
Hypothesis
Can IL-6 administration prevent hypovolemic circulatory collapse (HCC) and associated cardiac dysfunction in a rat model?
Conclusion
IL-6 administration at the start of resuscitation significantly prevents HCC, improves cardiac function, and reduces mortality in rats subjected to hemorrhagic shock.
Supporting Evidence
- IL-6 treatment completely reversed HCC and prevented cardiac dysfunction.
- Mortality was reduced nearly 5-fold in rats treated with IL-6 compared to placebo.
- Cardiomyocyte apoptosis was significantly reduced in rats receiving IL-6.
Takeaway
When rats lose a lot of blood, they can get very sick. Giving them a special protein called IL-6 helps them recover and stay healthy.
Methodology
Rats were subjected to a hemorrhagic shock protocol and treated with IL-6 or placebo to assess the effects on cardiac function and apoptosis.
Limitations
The study was conducted in a rat model, which may not fully replicate human responses to hemorrhagic shock.
Participant Demographics
Adult male Sprague-Dawley rats were used in the study.
Statistical Information
P-Value
p<0.005
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website